ReachMD
CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Visita il sito del podcast e sostieni chi lo crea: reachmd.com
Dove ascoltare?
I podcast nell'app Replaio Radio In arrivoI podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast
Installala gratis
Android quasi 10 mln di download · valutazione 4,8
iOS in arrivo
Episodi
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution 15.12.2025 5:00
Faculty: Michiel van de Sande, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhi...
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT 15.12.2025 5:00
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis 15.12.2025 24:15
Host: Pushpa Narayanaswami, MD, FAAN In this expert commentary, Dr. Narayanaswami highlights key messages from the Prova Education satellite symposium held at the 2025 AANEM Meeting in San Francisco. The discussion centers on the clinical application of FcRn antagonists in gMG, reviewing the rationale for FcRn blockade, approved FcRN antagonists, and pivotal clinical trial data. Differences in the...
Are You On Top of Pediatric Atopic Dermatitis? Expert Guidance for Leveraging the Latest Advances in Systemic Therapy 15.12.2025 54:30
Host: Peter A. Lio, MD Guest: Wendy Smith Begolka Guest: Elizabeth Swanson, MD, FAAD On-demand webcast of expert faculty presentation on the disease burden of pediatric atopic dermatitis and strategies for helping patients achieve disease control with systemic therapy.
All Sides of the Joint: Integrated TGCT Care Across Specialties 15.12.2025 5:30
Faculty: A.J. Gelderblom, MD, PhD Faculty: Michiel van de Sande, MD, PhD Faculty: Chelsea Cole, MD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The...
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy 15.12.2025 5:15
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT 15.12.2025 5:15
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians 15.12.2025 4:45
Faculty: A.J. Gelderblom, MD, PhD Faculty: Chelsea Cole, MD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical...
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs 15.12.2025 5:45
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT 15.12.2025 5:00
Faculty: A.J. Gelderblom, MD, PhD Faculty: Michiel van de Sande, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence...
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R 15.12.2025 4:45
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices 15.12.2025 4:45
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution 15.12.2025 5:00
Faculty: Michiel van de Sande, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhi...
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT 15.12.2025 5:00
Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis 15.12.2025 24:15
Host: Pushpa Narayanaswami, MD, FAAN In this expert commentary, Dr. Narayanaswami highlights key messages from the Prova Education satellite symposium held at the 2025 AANEM Meeting in San Francisco. The discussion centers on the clinical application of FcRn antagonists in gMG, reviewing the rationale for FcRn blockade, approved FcRN antagonists, and pivotal clinical trial data. Differences in the...
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Current Treatment of Hepatic Encephalopathy: Is It Meeting Our Patients' Needs? 11.12.2025 4:45
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
Optimizing Care of the Hospitalized Patient With Overt Hepatic Encephalopathy 11.12.2025 5:15
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Treatment of Hepatic Encephalopathy: Primary vs Secondary Prophylaxis 11.12.2025 5:15
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Treatment of Hepatic Encephalopathy: When, What, How, and Why? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
The Slippery Slope of Overt Hepatic Encephalopathy 11.12.2025 4:30
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Minimal Hepatic Encephalopathy: A Covert Operation? 11.12.2025 5:00
Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidence-b...
Minimal Hepatic Encephalopathy: Hiding in Plain Sight? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Hepatic Encephalopathy: More Common Than You Think 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmacologic therapy, and evidenc...
Advances in the Treatment of Overt Hepatic Encephalopathy: What's in the Pipeline? 11.12.2025 5:00
Faculty: Arun B. Jesudian, MD Faculty: Nancy S. Reau, MD T his series of brief episodes focuses on the early recognition and clinical management of hepatic encephalopathy (HE). Drs. Arun Jesudian and Nancy Reau examine subtle signs that may indicate minimal or covert HE and offer strategies for timely diagnosis. The discussion covers practical tools for detection, the role of nutrition and pharmac...
Podcast simili
Ascolta il podcast CME/CE su Replaio
Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio
Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici
